US OptionsDetailed Quotes
RIGL241220P25000
- 6.70
- 0.000.00%
15min DelayTrading Dec 13 15:07 ET
0.00High0.00Low
0.00Open6.70Pre Close0 Volume30 Open Interest25.00Strike Price0.00Turnover132.14%IV4.54%PremiumDec 20, 2024Expiry Date5.83Intrinsic Value100Multiplier4DDays to Expiry0.87Extrinsic Value100Contract SizeAmericanOptions Type-0.9677Delta0.0290Gamma3.28Leverage Ratio-0.0174Theta-0.0017Rho-3.17Eff Leverage0.0015Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet